Responses
Other responses
Jump to comment:
- Published on: 22 March 2016
- Published on: 22 March 2016
- Published on: 22 March 2016Caution in considering the diagnostic utility of antibasal ganglia antibodiesShow More
Dear Editor,
The authors appreciate the comments of Dr Giovannoni and fully recognize the ongoing efforts of the London group in evaluating antibasal ganglia antibodies (ABGA) in poststreptococcal movement conditions. Nevertheless, readers must recognize that there are significant discrepancies between results reported in the article by Church et al., [1] and other investigators [2,3].
In or...
Conflict of Interest:
None declared. - Published on: 22 March 2016Anti-basal ganglia antibodies in movement disordersShow More
Dear Editor,
In their commentary in response to our study on the diagnostic utility of anti-basal ganglia antibodies (ABGA) in post-streptococcal movement disorders, Singer and colleagues [1] raise certain points and present laboratory data which require a considered response.
The band at ~55 kDa appears to be in saturation and the number of bands detected raises the issue of non-specific or low affini...
Conflict of Interest:
None declared.